Skip to main content
SpringerLink
Log in

Lipid-Lowering Agents

  • Chapter
  • First Online:
Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care

  • 4619 Accesses

Abstract

One of the most important jobs as an anesthesiologist is to reduce the incidence of adverse perioperative outcome and reduce the incidence of morbidity and mortality associated with various surgeries. Historically, this has been done through applying various medical therapies perioperatively and even postoperatively. Searching for the best therapies is a constant, ongoing pursuit to better the field of anesthesiology. Two huge examples of this ongoing pursuit to find medical therapies to reduce morbidity and mortality in the perioperative period include the use of pre-incision prophylactic antibiotics and perioperative beta-blockade. Another huge modality that is gaining interest is the use of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known as statins, as well as other lipid-lowering drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mahley RW, Bersot TP. Chapter 35: Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s The pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill; 2006.

    Google Scholar 

  2. Aguila-Salinas CA, Barrett H, Schonfeld G. Metabolic modes of action of the statins in the hyperlipoproteinemias. Atherosclerosis. 1998;141:203–7.

    Article  Google Scholar 

  3. Katzung BG, Masters SB, Trevor AJ. Basic and clinical pharmacology. 11th ed. New York: McGraw-Hill companies; 2009.

    Google Scholar 

  4. Biccard BM. A peri-operative statin update for non-cardiac surgery. Part I: the effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients. Anaesthesia. 2008;63:52–64.

    Article  CAS  PubMed  Google Scholar 

  5. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet. 2002;41(5):343–70.

    Article  CAS  PubMed  Google Scholar 

  6. Gajendragadkar PR, Cooper DG, Walsh SR, et al. Novel uses for statins in surgical patients. Intl J Surg. 2009;7:285–90.

    Article  CAS  Google Scholar 

  7. Williams TM, Harken AH. Statins for surgical patients. Ann Surg. 2008;247:30–7.

    Article  PubMed  Google Scholar 

  8. Rosenson RS, Tagney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998;279:1643–50.

    Article  CAS  PubMed  Google Scholar 

  9. Cohen MC, Artz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol. 1999;8:133–9.

    Article  CAS  PubMed  Google Scholar 

  10. Dawood MM, Gupta DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction; implications regarding pathophysiology and prevention. Intl J Cardiol. 1996;57:37–44.

    Article  CAS  Google Scholar 

  11. Li JJ, Li YS, Chen J, et al. Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy. Med Hypotheses. 2006;66:1199–204.

    Article  CAS  PubMed  Google Scholar 

  12. Werner N, Nickenig G, Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol. 2002;97:105–16.

    Article  CAS  PubMed  Google Scholar 

  13. Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler ThrombVasc Biol. 2003;23:729–36.

    Article  CAS  Google Scholar 

  14. Manach YL, et al. Statin therapy within the perioperative period. Anesthesiology. 2008;108:1141–6.

    Article  PubMed  Google Scholar 

  15. Rossi S, editor. Australian medicines handbook 2006. Adelaide: Australian Medicines Handbook; 2006.

    Google Scholar 

  16. Armitage J. The safety of statins in clinical practice. Lancet. 2007;370:1781–90.

    Article  CAS  PubMed  Google Scholar 

  17. Calderon RM, et al. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc. 2010;85:349–56.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Ballantyne CM, Corsini A, Davidson MH, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003;163:553–64.

    Article  CAS  PubMed  Google Scholar 

  19. Black DM. A general assessment of the safety of HMG CoA reductase inhibitors (statins). Curr Artheroscler Rep. 2002;4:34–41.

    Article  Google Scholar 

  20. Ridker PM, Danielson E, Fonseca FA, JUPITER Study Group, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–207.

    Article  CAS  PubMed  Google Scholar 

  21. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375:735–42.

    Article  CAS  PubMed  Google Scholar 

  22. Corsini A, Bellosta S, Baetta R, et al. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol. Ther. 1999;84:413–28.

    Article  CAS  PubMed  Google Scholar 

  23. Schouten O, Hoeks SE, Welten G, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007;100:316–20.

    Article  CAS  PubMed  Google Scholar 

  24. American College of Cardiology/American Heart Association/National Heart Lung Blood Institute. Clinical advisory on the use and safety of Statins. J Am Coll Cardiol. 2002;40:567–72.

    Article  Google Scholar 

  25. Schouten O, Kertai MD, Bax JJ, et al. Safety of perioperative statin use in high-risk patients undergoing vascular surgery. Am J Cardiol. 2005;95:658–60.

    Article  CAS  PubMed  Google Scholar 

  26. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.

    Google Scholar 

  27. Grundy SM, Cleeman JL, Merz CN, et al. Implications of recent trials for the national cholesterol education program adult treatment Panel III guidelines. Circulation. 2004;110:227–39.

    Article  PubMed  Google Scholar 

  28. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2007;116:e418–99.

    Article  PubMed  Google Scholar 

  29. Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ. Effect of stain use within the first 24 hours of administration for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005;96:611–6.

    Article  CAS  PubMed  Google Scholar 

  30. National Confidential Enquiry into Patient Outcome and Death. Report-abdominal aortic aneurysm: a service in need of surgery? London: NCEPOD; 2005. http://www.ncepod.org.uk/2005report2/Downloads/AAA_report.doc2005.

  31. Conte MS, Bandyk DF, Clowes AW, et al. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005;42:829–36; discussion 836–7.

    Article  Google Scholar 

  32. Bicard BM. A peri-operative statin update for non-cardiac surgery. Part II: statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia. 2008;63:162–71.

    Article  Google Scholar 

  33. American Heart Association. Cardiovascular disease statistics. 2006. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4478.

  34. British Heart Foundation statistics website. CVD mortality in Europe. 2005. Available at: http://www.heartstats.org/topic.asp?id=753.

Download references

Acknowledgements

The editors and publisher would like to thank Drs. Alan Kaye and Phillip Kalarickal for contributing to the chapter on this topic in the prior edition. It has served as the foundation for the chapter.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Tulane University School of Medicine, New Orleans, LA, USA

    Scott D. Friedman MD & Brian McClure

Authors
  1. Scott D. Friedman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian McClure
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian McClure .

Editor information

Editors and Affiliations

  1. Departments of Anesthesiology and Pharmacology, LSU Health Sciences Center, New Orleans, Louisiana, USA

    Alan David Kaye

  2. Department of Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences, Stockton, California, USA

    Adam M. Kaye

  3. Center for Perioperative Management and Medical Informatics, Brigham and Women’s Hospital, Boston, Massachusetts, USA

    Richard D. Urman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Friedman, S.D., McClure, B. (2015). Lipid-Lowering Agents. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8948-1_48

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8947-4

  • Online ISBN: 978-1-4614-8948-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation